Macquarie has lowered its price target for Core Scientific (CORZ) from $38 to $25, while reiterating an Outperform rating. This adjustment reflects a revised valuation by the firm, likely influenced by recent market volatility in the data-center and chip sectors, suggesting a more cautious outlook on CORZ's near-term growth prospects despite continued long-term optimism.
Macquarie has reduced its price target for Core Scientific (CORZ) from $38 to $25, although it maintained an 'Outperform' rating. This move signals a recalibration of Macquarie's valuation model for CORZ, likely due to broader market volatility impacting data-center and chip-related stocks. For traders, this is a moderately negative signal in the short term as it implies a lower perceived upside, potentially leading to some selling pressure. However, the maintained 'Outperform' rating suggests Macquarie still sees long-term value, which could limit significant downside. The key risk is whether other analysts follow suit, further dampening investor sentiment, while the opportunity lies in potential overreactions if the market disproportionately punishes CORZ despite the continued positive rating.